Bhinneka News Online: Reuters Health Report: April 18, 2017

Tuesday, 18 April 2017

Reuters Health Report: April 18, 2017

Click to View in Browser

Tuesday, April 18, 2017

Novartis advances with push on cancer and liver disease

ZURICH (Reuters) - Novartis's push into oncology and liver disease, two of its treatment priorities, advanced on Monday as the Swiss drugmaker won a second U.S. breakthrough tag for its cancer gene therapy while striking a separate pact with Allergan.

South Korea to downgrade bird flu alert status from highest level

SEOUL (Reuters) - South Korea will downgrade its bird flu alert level by one notch from the highest level starting from Wednesday as no new cases have been reported for about two weeks, the country's agriculture ministry said on Tuesday.

Circassia gives up on allergy after house dust mite study fails

LONDON (Reuters) - Britain's Circassia Pharmaceuticals is throwing in the towel on allergy investment after a second high-profile clinical trial flop, focusing instead on building a broader respiratory business.

Women may be less apt to get surgery in war-torn countries

(Reuters Health) - Working as a surgeon in sub-Saharan Africa, Dr. Sherry Wren couldn't help but wonder why so many more men than women sought her care.

Roche's Tecentriq wins FDA approval for treating advanced bladder cancer

(Reuters) - Genentech, a unit of Swiss drugmaker Roche Holding AG, said on Monday it got approval from the U.S. Food and Drug Administration for its already approved immunotherapy drug, Tecentriq, to treat advanced bladder cancer.

Theranos reaches agreement with U.S. health regulator

(Reuters) - Theranos Inc said on Monday it would stay out of the blood-testing business for at least two years in exchange for reduced penalties from federal health authorities.

Roche's emicizumab hemophilia drug shows positive results with children

ZURICH (Reuters) - Roche Holding AG's emicizumab drug for treating hemophilia A showed positive interim results in a phase III study with children with inhibitors to clotting protein factor VIII, the Swiss drugmaker said on Monday.

OncoMed's lung cancer drug fails mid-stage study, shares tumble

(Reuters) - OncoMed Pharmaceuticals Inc's shares were jolted for a second time in a week after the company said on Monday its experimental lung cancer drug failed a mid-stage study.

Pregnant teens more likely to smoke pot than other girls

(Reuters Health) - Adolescent girls are more than twice as likely to smoke marijuana if they're pregnant, a U.S. study suggests.

Anti-depressant use before, during pregnancy tied to autism risk

(Reuters Health) - Antidepressant use right before and during pregnancy may be linked with a higher risk of an autism spectrum disorder (ASD) in children, hints a new analysis of past research.